✉news BusinessStartups first seen 4 h ago, last 51 min ago, peak #15
TRex Bio sets price range for $133 million IPO
Original: Immunology startup TRex Bio sets price range for $133 million public debut
Immunology startup TRex Bio has set the price range for its planned initial public offering, which would raise around $133 million. The debut will put the spotlight on investor appetite for biotech listings, with the company developing treatments based on immune-regulation science. Details on valuation and listing timing are expected as the offering books are built.
Why now: A new biotech IPO is launching, and investors are watching whether market conditions will support startup public debuts.
Rank over time, top of the chart is #1. 4 snapshots from 4 h ago to 51 min ago.
Evidence
- Immunology startup TRex Bio sets price range for $133 million public debut · Yahoo Finance
- Immunology startup TRex Bio sets price range for $133 million public debut · StreetInsider
API: https://socialmediatrends-api.osmike.com/v1/trends/1121577